Here are several factors that are either supporting or hampering growth for ASCs in 2025: Harmful factors: 1. Stagnating reimbursement rates Reimbursement rates have not kept pace with inflation and ...

The state’s 15 hospital districts are among hundreds of entities that will see tax revenue declines. It’s a blow to an already fragile sector, health care representatives say.

Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the ...

A draft of the White House budget plan for the Health and Human Services Department includes a call for greater scrutiny of ...

Regeneron Pharmaceuticals has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its Eylea HD eye drug.

The sBLA seeks approval for Eylea HD for both the treatment of macular edema following retinal vein occlusion, and for ...

In fact, healthcare costs in India were 3.3% of the GDP in 2022, but are slated to rise to 5% by 2030, reports The Economic Times, citing a study by CareEdge.